Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ipca Laboratories Ltd. Capital/Financing Update 2022

Dec 19, 2022

61700_rns_2022-12-19_356fc8b4-b4ed-44df-9ec3-245a883aad8f.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

THRU ONLINE FILING

December 19, 2022

BSE Ltd. Phiroze Jeejeebhoy Towers Dalai Street Mumbai 400 023 Scrip Code - 524494

National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra - (East). Mumbai-400051. Scrip Code : IPCALAB

Dear Sirs,

Re: Acquisition of further 6.53% of the paid-up equity share capital of M/s. Trophic Wellness Pvt. Ltd. (TWPL)

We are pleased to inform you that the Company has acquired further 6.53% of the paid-up equity share capital of M/s. Trophic Wellness Private Ltd. (TWPL), a company incorporated under the Companies Act, 1956 and engaged in the business of manufacturing and marketing several SKUs of Neutraceuticals under the brand name "Nutricharge".

With the acquisition of these further 6.53% of the equity share capital of the said M/s. Trophic Wellness Pvt. Ltd., the Company now holds 58.88% of the paid-up equity share capital of said company.

The required disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed herewith.

Thanking you

Yours faithfully For Ipca Laboratories Limited Digitally signed by HARISH PANDURANG KAMATH

DN: c=IN, o=PERSONAL, 2.5.4.20=3e5648a57390d9262997da3de9051643bfb 87e352b111402af42d207e52e25c6, postalCode=400063, st=Maharashtra, serialNumber=72050fb9fadcbc5de6404685117b835 5792f5784c7617d9c4cae2a3887d6b809, cn=HARISH PANDURANG KAMATH Date: 2022.12.19 18:09:20 +05'30'

HARISH PANDURANG KAMATH

Harish P. Kamath Corporate Counsel & Company Secretary

Enel: a/a

125, Kandivli Industrial Estate, CT5 No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T:+91 22 6210 5000 F:+91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6647 4444 E: [email protected] CIN: L24239MH1949PLC007837

DISCLOSURE UNDER REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND

DISCLOSURE REQUIREMENTS) REGULATIONS, 2015

ACQUISITION OF FURTHER 6.53% OF THE PAID-UP SHARE CAPITAL OF M/S. TROPHIC WELLNESS PVT. LTD. (TWPL)

a. Name of the target entity, details in brief
such as size, turnover
etc
Trophic Wellness
Pvt. Ltd. (TWPL)
(CIN U24100MH2010PTC206526)
142-AB, Kandivli Industrial Estate
Kandivli (West), Mumbai -
400 067
For the financial year ended 31st March 2022:
96.75 crores
Total Income
: Rs.
EBIDTA
24.70 crores
: Rs.
Profit Before Tax : Rs.
22.72 crores
Profit After
Tax
17.04 crores
: Rs.
TWPL
engaged
the
business
of
is
in
manufacturing and marketing of
several SKUs of
Neutraceuticals
under
the
brandname
"Nutricharge".
The
company's
manufacturing
facility is situated at Sikkim.
TWPL is debt free.
b. Whether
the acquisition would fall within
related party transaction(s) and whether
the promoter/ promoter
group/
group
companies have any interest in the
entity being acquired? If yes, nature of
interest and details thereof
and whether
the same is done at "arms
length"
acquisition
This
does
not
fall
within
the
related
/
transaction
the
promoter
promoter
party
and
group/ group companies
interest
have
no
in the
shares being acquired.
c. Industry to which the entity being
acquired belongs
TWPL
engaged
the
business
of
is
in
manufacturing and marketing of several SKUs of
under
Neutraceuticals
the
brandname
"Nutricharge".
d. Objects and effects of acquisition
(including but not limited to, disclosure
of reasons for
acquisition of target
entity, if its business is outside the main
line of business of
the listed entity)
This
further
acquisition of shares will consolidate
the Company's holding in this profitable subsidiary
the
Company
to
grow
and
wil
help
its
neutraceuticals portfolio and business.
e. Brief details of any governmental or
regulatory approvals required for
the
acquisition
Prior governmental
or regulatory
approval
not
is
required for
this acquisition.
f. Indicative time period for
completion of
the acquisition
This acquisition is made from
9.12.2022 to
16.12.2022.
_ __________Ipra I ahnratnrip<; I tH

www.ipca.com

9- Nature of
consideration - whether
cash consideration or share swap
and details of the same
Cash Consideration of Rs.
10.58 crores for
2,64,600
equity
shares
of
TWPL
acquired
400/-
per
@
Rs.
share.
h. Cost of acquisition or the price at
which the shares are acquired
Cash Consideration of Rs.
10.58 crores was paid for
acquisition
of
shareholding
the
additional
6.53%
of
-
TWPL
2,64,600
equity
shares
400/-
@
per
Rs.
share.
Percentage of
shareholding /
control acquired and /
or number of
shares acquired
additional
acquisition
of
With
this
6.53%
of
shareholding
TWPL,
Company
the
now
holds
in
58.88% of
TWPL's
paid up equity share capital.
J Brief background about the entity
acquired in terms of products/line
of business acquired, date of
incorporation, history of last 3
years turnover, country in which
the acquired entity has presence
and any other significant
information (in brief)
Trophic
Wellness
(TWPL),
company
Pvt.
Ltd.
a
in the year 2010
incorporated
under the Companies
engaged
Act,
1956
and
the
business
of
in
is
manufacturing
marketing
of
and
several
SKUs
of
brandname "Nutricharge".
Neutraceuticals
under the
Company's
manufacturing
facility
The
situated
is
at
Sikkim.
registered
of
the
Company
is situated
The
office
at
Industrial
Plot
142-AB,
Kandivli
Estate,
Kandivli
(West), Mumbai -
400 067.
The financials of TWPL are as under:
(Financial year ended 31st March)
(Rs. Crores)
2022
(Audited)
2021
(Audited)
2020
(Audited)
Total Income 96.78 102.82 85.74
EBIDTA 24.70 32.91 24.51
Profit before
Tax
22.72 30.70 21.96
Provision for
Tax
5.68 8.93 6.44
Profit after tax 17.04 21.77 15.52
EPS 42.07 53.74 38.32
Share Capital 4.05 4.05 4.05
Reserves &
Surplus
97.37 80.36 58.58
Net worth 101.42 84.41 62.63
TWPL is debt free.

125, KandivlilndustrialEstate,CTSNo. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T:+91 22 6210 5000 F:+91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6647 4444 E: [email protected] CIN: L24239MH1949PLC007837